Domov › Množni mielom › New York › Queens
Klinične študije za Množni mielom v Queens, NY
20 študij za Množni mielom išče udeležence na lokacijah v Queens in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi stran
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Vključevanje udeležencevFaza 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi stran
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Vključevanje udeležencevFaza 3
- NYU Winthrop, Mineola · 11 mi stran
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
Vključevanje udeležencevFaza 3
- Northwell Health Cancer Institute, Lake Success · 9 mi stran
- NYU Langone Hospital Long Island, Mineola · 11 mi stran
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Vključevanje udeležencevFaza 3
- MSK Nassau, Uniondale · 13 mi stran
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Vključevanje udeležencevFaza 2
- Queens Cancer Center, Rego Park · 3 mi stran
- Cohen Children's Medical Center, New Hyde Park · 9 mi stran
- Northwell Health Monter Cancer Center, Lake Success · 9 mi stran
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi stran
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Vključevanje udeležencevFaza 3
- Long Island Jewish Medical Center, New Hyde Park · 9 mi stran
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi stran
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Vključevanje udeležencevFaza 3
- MSK Nassau, Uniondale · 13 mi stran
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Vključevanje udeležencevFaza 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi stran
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
Vključevanje udeležencevFaza 3
- Research Site, New Hyde Park · 9 mi stran
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Vključevanje udeležencevOpazovalna študija
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi stran
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Vključevanje udeležencevFaza 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi stran
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi stran
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi stran
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
Vključevanje udeležencevFaza 1/2
- Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi stran
A Dietary Study for People With Multiple Myeloma
Vključevanje udeležencev
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi stran
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Vključevanje udeležencevFaza 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi stran
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Memorial Sloan Kettering Rockville, Rockville Centre · 10 mi stran
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Vključevanje udeležencev
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi stran
Študije za Množni mielom v drugih mestih
- New York City, NY60 študij
- Boston, MA42 študij
- Atlanta, GA41 študij
- Houston, TX38 študij
- Durham, NC37 študij
- Nashville, TN32 študij
- Denver, CO27 študij
- Rochester, MN24 študij
- St. Louis, MO24 študij
- Columbus, OH24 študij
- Baldwin Park, CA23 študij
- Chicago, IL22 študij
Druge študije v Queens
- Rak dojke63 študij
- Nemalicelični pljučni rak49 študij
- Kolorektalni rak31 študij
- Metastatski rak28 študij
- Rak jajčnikov28 študij
- Rak prostate27 študij
- Rak (vse vrste)26 študij
- Rak endometrija25 študij
- Rak pljuč22 študij
- Akutna mieločna levkemija21 študij
- Ploščatocelični karcinom glave in vratu20 študij
- Rak trebušne slinavke20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.